Knockdown of ZBTB11 impedes R‐loop elimination and increases the sensitivity to cisplatin by inhibiting DDX1 transcription in bladder cancer

INTRODUCTION: Bladder cancer (BC) is one of the most common malignant cancers, with poor prognosis and high incidence. Cisplatin is the standard chemotherapy for muscle invasive bladder cancer; however, chemotherapy resistance remains a major challenge. Moreover, oncogenic signalling and the specifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lei, Liu, Zefu, Tang, Huancheng, Zhou, Zhaohui, Chen, Jiawei, Ma, Zikun, Deng, Minhua, Li, Xiangdong, Wu, Yuanzhong, Zheng, Lisi, Zhou, Liwen, Zheng, Xianchong, Liu, Zhuowei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715355/
https://www.ncbi.nlm.nih.gov/pubmed/36054300
http://dx.doi.org/10.1111/cpr.13325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715355/
https://www.ncbi.nlm.nih.gov/pubmed/36054300
http://dx.doi.org/10.1111/cpr.13325

Ejemplares similares